+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Possible role of hyperinsulinemia in pathogenesis of acute and chronic cardiac failure in patients with ischemic heart disease (data of clinical studies)



Possible role of hyperinsulinemia in pathogenesis of acute and chronic cardiac failure in patients with ischemic heart disease (data of clinical studies)



Kardiologiia 46(6): 43-48



Changes of blood insulin content were studied in patients with ischemic heart disease with various functional classes of acute and chronic heart failure and at different disease stages. It was established that latent hyperinsulinemia which became evident at induced myocardial ischemia was present on all stages of development of ischemic heart disease. In acute heart failure due to developed myocardial infarction hyperinsulinemia manifested in 58.3% of patients. Amount of insulin in blood increased almost 3 times. During progression of chronic heart failure insulin content significantly decreased, probably because of exhaustion of insulin producing function and development of its relative or absolute deficit. At terminal stage of congestive heart failure insulin level was < or = 1 microU/ml. The authors believe that severity of clinical signs of acute and chronic heart failure are determined by sensitivity of myocardium to insulin, content of insulin in blood, and also depends on compensatory possibilities of insulin producing function at each stage of development of the disease.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049956911

Download citation: RISBibTeXText

PMID: 16883222


Related references

Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial. Journal of Cardiac Failure 13(10): 797-804, 2007

Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial. American Heart Journal 155(6): 1106-1113, 2008

The role of interventricular septum in kinetics of left and right ventricular contraction in patients with ischemic heart disease and chronic cardiac failure. Terapevticheskii Arkhiv 78(12): 19-24, 2006

Effect of Bonnecor on clinical manifestations, bioelectric cardiac activity and cardiac hemodynamics in patients with acute myocardial infarction and chronic ischemic heart disease. Klinicheskaia Meditsina 68(2): 44-46, 1990

QRS prolongation in the prediction of clinical cardiac events in patients with acute heart failure: analysis of data from the Korean Acute Heart Failure Registry. Cardiology 125(2): 96, 2013

A randomized clinical trial of hospital-based, comprehensive cardiac rehabilitation versus usual care for patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease (the DANREHAB trial)--design, intervention, and population. American Heart Journal 150(5): 899, 2005

Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease. Terapevticheskii Arkhiv 76(3): 62-68, 2004

Several aspects of the pathogenesis of chronic circulatory failure in ischemic heart disease: role of atrial natriuretic peptide. Kardiologiia 30(9): 28-30, 1990

Role of the individual links in the blood coagulation system in the pathogenesis of different stages of heart failure in patients with ischemic heart disease. Kardiologiia 26(7): 107-108, 1986

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Seminars in Dialysis 16(2): 111-117, 2003

Pathogenesis, diagnosis and conservative treatment of ischemic heart disease in patients with chronic renal failure. Polskie Archiwum Medycyny Wewnetrznej 104(4): 671-679, 2000

Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure). Circulation 135(12): 1136-1144, 2017

Association between β-blocker Therapy and Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Lung Disease with Underlying ischemic Heart Disease, Heart Failure or Hypertension. Journal of Emergency Medicine 44(1): 284-285, 2013

Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischernic heart disease: 12-Month results of a randomized clinical trial (vol 155, pg 1106, 2008). 2007

Non-invasive prognostic factors in chronic heart failure. One-year survival of 300 patients with a diagnosis of chronic heart failure due to ischemic heart disease or dilated cardiomyopathy. International Journal of Cardiology 56(3): 283-288, 1996